Summary
The product BPC-157 (5 mg/vial) by PHARMAQO underwent independent testing for concentration and purity. Submitted by Pharmaqo Labs (mrp@vitamins.to), the sample analysis was conducted by Janoshik Analytical. The measured concentration was 4.46 mg with a purity of 99.091%.
Testing was initiated on 25 January 2024, with the sample received on 31 January 2024. The analysis was completed on 1 February 2024.
Detailed Report
Product Overview
- Manufacturer: Pharmaqo Labs
- Product Name: BPC-157 (5 mg/vial)
- Active Ingredient: Body Protection Compound-157
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Lyophilized (Freeze-Dried) Powder
Sample Acquisition and Testing
- Task Number: #38208
- Testing Ordered: 25 January 2024
- Sample Received: 31 January 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Pharmaqo Labs (Manufacturer)
- Analysis Paid For By: Pharmaqo Labs (Manufacturer)
Testing Results
- Label Specification: 5 mg
- Measured Concentration: 4.46 mg
- Purity: 99.091%
- Accuracy: 89.2%
Verification Details
- Verification URL: https://janoshik.com/tests/38208_RCQ75I8TGUUW
Evaluation of Manufacturer-Submitted Testing
The product demonstrates high purity at 99.091%, indicating minimal impurities or contaminants. However, the measured concentration of 4.46 mg falls short of the claimed 5 mg label, with an accuracy level of 89.2%. This discrepancy might warrant further testing or clarification from the manufacturer.
Conclusion
While the purity is excellent, the underdosing of BPC-157 at 4.46 mg versus the labeled 5 mg specification could be a concern for users requiring precise dosing. Further investigation is recommended to validate the consistency of product quality.
Disclaimer
This report is for educational purposes and highlights findings based on manufacturer-submitted testing. Independent third-party testing is advised for comprehensive validation.
